Clinical Trials Browser

OTHER × Atrial Fibrillation × Other hematologic neoplasm × Clear all

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

NCT05643235 2025-09-18

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Atrial Fibrillation, Heart Arrest, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Death, Sudden, Cardiac, Lymphoma, Mantle-Cell

NCT06224452 2024-03-05

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

Unknown

18,000 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT06130709 2023-11-14

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

Unknown

100 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT06029166 2023-09-08

IRAF-ISCM

Phase NA Not yet recruiting

100 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms, Cardiotoxicity

NCT04407845 2020-06-09

FABRIC

Unknown

60 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Clinical Trials

SENTINEL

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

IRAF-ISCM

FABRIC